磁共振成像在肺动脉高压患者预后评估中的价值
该研究基于ASPIRE注册研究,纳入576例肺动脉高压患者,随访42个月(范围17-142个月),其中221例(38%)死亡。通过多变量Cox回归发现右心室收缩末期容积指数(校正年龄和性别)和肺动脉相对面积变化是两个独立的MRI死亡预测因子。结合MRI与临床数据的模型在验证队列中预测1年和3年死亡具有中等准确性,在特发性肺动脉高压患者中3年预测更准确。
要点
- 右心室收缩末期容积指数和肺动脉相对面积变化是肺动脉高压患者死亡的独立MRI预测因子。
- MRI联合临床数据的模型预测1年死亡敏感性70%、特异性62%,3年敏感性77%、特异性73%。
- 该模型在特发性肺动脉高压患者3年预测中敏感性89%、特异性76%。
核心结论
- 反映右心室结构和近端肺血管僵硬度的MRI指标是肺动脉高压患者结局的独立预测因子。
- MRI联合临床数据对肺动脉高压患者预后的评估具有中等准确性。
研究设计与样本
- 来自ASPIRE肺动脉高压注册研究的连续肺动脉高压患者,均接受MRI检查。
- 随访期间共研究576例患者,其中221例(38%)死亡;推导队列288例(115例死亡),验证队列288例(106例死亡)。
- 采用多变量Cox回归分析MRI指标的预测价值。
主要发现
- 多变量Cox回归发现两个独立的MRI死亡预测因子(P < 0.01):校正年龄和性别的右心室收缩末期容积指数,以及肺动脉相对面积变化。
- 推导队列构建的MRI联合临床数据模型在验证队列中预测1年死亡率:敏感性70(95% CI 53-83),特异性62(95% CI 62-68),阳性预测值24(95% CI 16-32),阴性预测值92(95% CI 87-96)。
- 预测3年死亡率:敏感性77(95% CI 67-85),特异性73(95% CI 66-85),阳性预测值56(95% CI 47-65),阴性预测值87(95% CI 81-92)。
- 在特发性肺动脉高压患者中3年预测更准确:敏感性89(95% CI 65-84),特异性76(95% CI 65-84),阳性预测值60(95% CI 46-74),阴性预测值94(95% CI 85-98)。
临床怎么用
- 在肺动脉高压患者预后评估中,可结合MRI测量的右心室收缩末期容积指数和肺动脉相对面积变化与临床数据共同判断死亡风险。
- MRI联合临床数据模型对1年和3年死亡预测具有中等准确性,在特发性肺动脉高压患者中3年预测准确性较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Prognostication is important when counseling patients and defining treatment strategies in pulmonary arterial hypertension (PAH). OBJECTIVES: To determine the value of magnetic resonance imaging (MRI) metrics for prediction of mortality in PAH. METHODS: Consecutive patients with PAH undergoing MRI were identified from the ASPIRE (Assessing the Spectrum of Pulmonary Hypertension Identified at a Referral Centre) pulmonary hypertension registry. MEASUREMENTS AND MAIN RESULTS: During the follow-up period of 42 (range, 17-142) months 576 patients were studied and 221 (38%) died. A derivation cohort (n = 288; 115 deaths) and validation cohort (n = 288; 106 deaths) were identified. We used multivariate Cox regression and found two independent MRI predictors of death (P < 0.01): right ventricular end-systolic volume index adjusted for age and sex, and the relative area change of the pulmonary artery. A model of MRI and clinical data constructed from the derivation cohort predicted mortality in the validation cohort at 1 year (sensitivity, 70 [95% confidence interval (CI), 53-83]; specificity, 62 [95% CI, 62-68]; positive predictive value [PPV], 24 [95% CI, 16-32]; negative predictive value [NPV], 92 [95% CI, 87-96]) and at 3 years (sensitivity, 77 [95% CI, 67-85]; specificity, 73 [95% CI, 66-85]; PPV, 56 [95% CI, 47-65]; and NPV, 87 [95% CI, 81-92]). The model was more accurate in patients with idiopathic PAH at 3 years (sensitivity, 89 [95% CI, 65-84]; specificity, 76 [95% CI, 65-84]; PPV, 60 [95% CI, 46-74]; and NPV, 94 [95% CI, 85-98]). CONCLUSIONS: MRI measurements reflecting right ventricular structure and stiffness of the proximal pulmonary vasculature are independent predictors of outcome in PAH. In combination with clinical data MRI has moderate prognostic accuracy in the evaluation of patients with PAH.
引用
- Swift AJ, Capener D, Johns C, et al. Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2017. PMID: 28328237. doi:10.1164/rccm.201611-2365OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。